The option of HBIG-free prophylaxis against recurrent HBV

Summary Since the early 1990’s, hepatitis B immune globulin (HBIG) has been central to the prevention of hepatitis B virus (HBV) recurrence after liver transplantation. When used in combination with oral nucleos(t)ide analogues, HBIG prevents reinfection with HBV in ⩾90% of transplant recipients. Wh...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of hepatology 2012-05, Vol.56 (5), p.1189-1197
Hauptverfasser:	Fox, Alyson N, Terrault, Norah A
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - therapeutic use Biological and medical sciences Gastroenterology and Hepatology Gastroenterology. Liver. Pancreas. Abdomen Hepatitis B - drug therapy Hepatitis B - prevention & control Hepatitis B - surgery Humans Immunoglobulins - therapeutic use Liver Transplantation Medical sciences Nucleosides - therapeutic use Nucleotides - therapeutic use Secondary Prevention Withholding Treatment - economics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!